On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
We are very excited to launch our new website! Please take a few moments to click around and explore...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...